Drop and Swell: Unanticipated Corneal Edema From Netarsudil Therapy

Neovascular glaucoma (NVG) poses significant treatment challenges, often necessitating complex medication regimens to manage intraocular pressure (IOP). This report details a 65-year-old male with NVG secondary to central retinal artery occlusion (CRAO), who developed corneal epithelial bullae as a rare side effect of topical netarsudil therapy. Despite this complication, a continued treatment led to the gradual resolution of corneal lesions while maintaining controlled IOP. This case underscores the importance of vigilant monitoring for adverse effects and highlights the need for further research into netarsudil's safety profile in NVG management.